Serum fibrosis markers could aid in the prediction of factor for successful oral antiviral treatment in hepatitis C.

Sahin, Memduh; Sucu, Pinar; Serin, Erdinc; Yetim, Aylin; Alkim, Huseyin; Alkim, Canan

Sahin, Memduh; Sucu, Pinar; Serin, Erdinc; Yetim, Aylin; Alkim, Huseyin; Alkim, Canan.

Sahin M; Department of Gastroenterology.
Sucu P; Department of Biochemistry.
Serin E; Department of Biochemistry, Saglik Bilimleri University Sisli Hamidiye Etfal Training and Research Hospital.
Yetim A; Department of Adolescence Medicine, Istanbul University Hospital.
Alkim H; Department of Gastroenterology.
Alkim C; Department of Gastroenterology, Saglik Bilimleri University Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.

Eur J Gastroenterol Hepatol ; 33(1S Suppl 1): e348-e354, 2021 12 01.

Article en En | MEDLINE | ID: mdl-33560684

Asunto(s)

Hepatitis C Crónica; Hepatitis C; Adulto; Anciano; Anciano de 80 o más Años; Antivirales/efectos adversos; Aspartato Aminotransferasas; Biomarcadores; Proteína 1 Similar a Quitinasa-3; Colágeno Tipo IV/uso terapéutico; Femenino; Fibrosis; Hepacivirus; Hepatitis C/diagnóstico; Hepatitis C/tratamiento farmacológico; Hepatitis C Crónica/diagnóstico; Hepatitis C Crónica/tratamiento farmacológico; Humanos; Ácido Hialurónico; Cirrosis Hepática; Masculino; Persona de Mediana Edad; Factor de Crecimiento Transformador beta

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hepatitis C / Hepatitis C Crónica Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google